About
I am a consultant Clinical Oncologist, specialising in adult brain tumours.
My NHS practice is based at Charing Cross Hospital, and I lead the Computational Oncology group at Imperial College.
My main clinical focus is on the development and clinical introduction of better treatments for brain tumour patients, with a focus on patient support.
I have led the introduction of Optune (Tumour-treating fields) for GBM in the UK and implemented the routine use of combined TMZ/Lomustine chemotherapy for patients with MGMT-methylated GBM - both treatments that are widely used in other countries.
I am also leading work in the UK around delivering stereotactic radiotherapy to patients with more brain metastases.
For patients who are interested in an appointment, I would suggest looking at HINO.org.uk which covers additional and novel treatments for brain tumour patients; for those interested in Optune (Tumour-treating Fields), please visit OptuneSupport.uk
I also work with two German groups to help patients access novel immunotherapies, and work closely with a US oncologist, Michael Castro, to try and deliver novel treatment approaches for patients in the UK.
Much of our research focuses on understanding care and outcomes at a national scale, and using digital technologies in neuro-oncology.
My NHS practice is based at Charing Cross Hospital, and I lead the Computational Oncology group at Imperial College.
My main clinical focus is on the development and clinical introduction of better treatments for brain tumour patients, with a focus on patient support.
I have led the introduction of Optune (Tumour-treating fields) for GBM in the UK and implemented the routine use of combined TMZ/Lomustine chemotherapy for patients with MGMT-methylated GBM - both treatments that are widely used in other countries.
I am also leading work in the UK around delivering stereotactic radiotherapy to patients with more brain metastases.
For patients who are interested in an appointment, I would suggest looking at HINO.org.uk which covers additional and novel treatments for brain tumour patients; for those interested in Optune (Tumour-treating Fields), please visit OptuneSupport.uk
I also work with two German groups to help patients access novel immunotherapies, and work closely with a US oncologist, Michael Castro, to try and deliver novel treatment approaches for patients in the UK.
Much of our research focuses on understanding care and outcomes at a national scale, and using digital technologies in neuro-oncology.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Matthew Williams
Education & training
-
2008–2014 MD · Medicine and Surgery
-
2014–2018 Residency · Oncology
-
2018–2019 Fellowship · Subspecialty training
Career & appointments
-
2018-09–2019-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
Generali Healthcare · 4,000,000 EUR coverage · No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 1,801 |
| Annual physical exam | 99395 | 831 |
| Vaccination administration | 90471 | 791 |
| Minor procedure (skin) | 17110 | 1,720 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 60 min | in_clinic | 180.00 EUR |
| Minor procedure (skin) | 90 min | in_clinic | 450.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 17 · i10: 16
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.5259/euroclin.2025.0 · PMID: 33905222 · cited by 129
-
European registry analysis of Oncology outcomes
DOI: 10.3261/euroclin.2024.1 · PMID: 33298325 · cited by 51
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.2953/euroclin.2023.2 · PMID: 37772184 · cited by 5
-
European registry analysis of Oncology outcomes
DOI: 10.7292/euroclin.2022.3 · PMID: 31818208 · cited by 55
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · London · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — London · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · Since 2019
- national college of family doctors — Member · Since 2019
- European Union of Medical Specialists (UEMS) — Member · Since 2019
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · matthew.williams@euroclinics.example
Location
1 tagPatient reviews
Share your experience — help other patients find the right doctor. Write a review →
Recent reviews
-
★★★★★ ✓ Verified Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verified Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verified Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
Similar specialists
Browse all →
Dr Anita Mitra
Oncology · London
Dr Jerome Michael Freund
Oncology · Wembley
Dr Marketa Skala
Oncology · Hobart
Dr Melanie Wai Yin Jackson
Oncology · Wembley
Dr Raphael John Chee
Oncology · Wembley
Dr Rebecca Tay
Oncology · Melbourne
Dr Cristina Moldovan
Oncology · Melbourne
Dr Wasiru Saka
Oncology · Milton Keynes